Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis of comparative effectiveness

被引:38
作者
Wright, Cameron M. [1 ]
Westerkamp, Lenna [2 ]
Korver, Sarah [3 ]
Dobler, Claudia C. [4 ,5 ]
机构
[1] Univ Tasmania, Sch Med, Div Pharm, Hobart, Tas, Australia
[2] Spectrum Hlth, Grand Rapids, MI USA
[3] Natl TB Ctr, Thimi, Nepal
[4] Univ Western Sydney, Sydney, NSW, Australia
[5] Univ Sydney, NHMRC Ctr Res Excellence TB Control, Sydney, NSW 2006, Australia
关键词
Tuberculosis; Directly observed therapy; DOT; Community-based DOT; Clinic DOT; Adherence; RANDOMIZED CONTROLLED-TRIAL; MULTIDRUG-RESISTANT TUBERCULOSIS; HEALTH EXTENSION WORKERS; TREATMENT OUTCOMES; COST-EFFECTIVENESS; ANTITUBERCULOSIS TREATMENT; TREATMENT DELIVERY; SOUTHERN ETHIOPIA; CAPE-TOWN; CARE;
D O I
10.1186/s12879-015-0945-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Directly observed therapy (DOT), as recommended by the World Health Organization, is used in many countries to deliver tuberculosis (TB) treatment. The effectiveness of community-based (CB DOT) versus clinic DOT has not been adequately assessed to date. We compared TB treatment outcomes of CB DOT (delivered by community health workers or community volunteers), with those achieved through conventional clinic DOT. Methods: We performed a systematic review and meta-analysis of studies before 9 July 2014 comparing treatment outcomes of CB DOT and clinic DOT. The primary outcome was treatment success; the secondary outcome was loss to follow-up. Results: Eight studies were included comparing CB DOT to clinic DOT, one a randomised controlled trial. CB DOT outperformed clinic DOT treatment success (pooled odds ratio (OR) of 1.54, 95% confidence interval (CI) 1.01 - 2.36, p = 0.046, I-2 heterogeneity 84%). No statistically significant difference was found between the two DOT modalities for loss to follow-up (pooled OR 0.86, 95% CI 0.48 to 1.55, p = 0.62, I-2 83%). Conclusions: Based on this systematic review, CB DOT has a higher treatment success compared to clinic DOT. However, as only one study was a randomised controlled trial, the findings have to be interpreted with caution.
引用
收藏
页数:11
相关论文
共 57 条
[1]   Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients [J].
Ahuja, Shama D. ;
Ashkin, David ;
Avendano, Monika ;
Banerjee, Rita ;
Bauer, Melissa ;
Bayona, Jamie N. ;
Becerra, Mercedes C. ;
Benedetti, Andrea ;
Burgos, Marcos ;
Centis, Rosella ;
Chan, Eward D. ;
Chiang, Chen-Yuan ;
Cox, Helen ;
D'Ambrosio, Lia ;
DeRiemer, Kathy ;
Nguyen Huy Dung ;
Enarson, Donald ;
Falzon, Dennis ;
Flanagan, Katherine ;
Flood, Jennifer ;
Garcia-Garcia, Maria L. ;
Gandhi, Neel ;
Granich, Reuben M. ;
Hollm-Delgado, Maria G. ;
Holtz, Timothy H. ;
Iseman, Michael D. ;
Jarlsberg, Leah G. ;
Keshavjee, Salmaan ;
Kim, Hye-Ryoun ;
Koh, Won-Jung ;
Lancaster, Joey ;
Lange, Christophe ;
de lange, Wiel C. M. ;
Leimane, Vaira ;
Leung, Chi Chiu ;
Li, Jiehui ;
Menzies, Dick ;
Migliori, Giovanni B. ;
Mishustin, Sergey P. ;
Mitnick, Carole D. ;
Narita, Masa ;
O'Riordan, Philly ;
Pai, Madhukar ;
Palmero, Domingo ;
Park, Seung-kyu ;
Pasvol, Geoffrey ;
Pena, Jose ;
Perez-Guzman, Carlos ;
Quelapio, Maria I. D. ;
Ponce-de-Leon, Alfredo .
PLOS MEDICINE, 2012, 9 (08)
[2]  
[Anonymous], COCHRANE HDB SYSTEMA
[3]  
[Anonymous], GLOB TUB REP 2013
[4]  
Arora V. K., 2003, Indian Journal of Tuberculosis, V50, P143
[5]  
Balasubramanian VN, 2000, INT J TUBERC LUNG D, V4, P409
[6]   DIRECTLY OBSERVED THERAPY FOR TUBERCULOSIS - HISTORY OF AN IDEA [J].
BAYER, R ;
WILKINSON, D .
LANCET, 1995, 345 (8964) :1545-1548
[7]  
Bhagyalaxmi A, 2010, Indian J Community Med, V35, P495, DOI 10.4103/0970-0218.74356
[8]  
Cavalcante SC, 2007, INT J TUBERC LUNG D, V11, P544
[9]  
Chowdhury AMR, 1997, LANCET, V350, P1108
[10]   Cost and Cost-Effectiveness of Smear-Positive Tuberculosis Treatment by Health Extension Workers in Southern Ethiopia: A Community Randomized Trial [J].
Datiko, Daniel G. ;
Lindtjorn, Bernt .
PLOS ONE, 2010, 5 (02)